Clinical Trial Update: Study of Oxytocin to Treat Vaginal Atrophy in Postmenopausal Women [Phase 2]

View source ↗

Summary

PepTonic Medical AB reports the completion of a Phase 2 trial evaluating oxytocin for vaginal atrophy in postmenopausal women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Atrophy

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: PepTonic Medical AB | Conditions: Postmenopause, Vaginal Atrophy | Phase 2 | Status: COMPLETED